21 Works

Additional file 1 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 1: Details of the search strategy. S1.1. Database search strategy. S1.1.2. Updated database search strategy. S1.2. Google scholar search strategy. S1.2.2. Updated google scholar search strategy. S1.3. Google engine search strategy.

Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Abstract Background The COVID-19 pandemic has highlighted the importance of evidence-based clinical decision-making. Clinical management guidelines (CMGs) may help reduce morbidity and mortality by improving the quality of clinical decisions. This systematic review aims to evaluate the availability, inclusivity, and quality of pandemic influenza CMGs, to identify gaps that can be addressed to strengthen pandemic preparedness in this area. Methods Ovid Medline, Ovid Embase, TRIP (Turning Research Into Practice), and Guideline Central were searched systematically...

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.

Mary-Ann Davies, Erna Morden, Petro Rosseau, Juanita Arendse, Jamy-Lee Bam, Linda Boloko, Keith Cloete, Cheryl Cohen, Nicole Chetty, Pierre Dane, Alexa Heekes, Nei-Yuan Hsiao, Mehreen Hunter, Hannah Hussey, Theuns Jacobs, Waasila Jassat, Saadiq Kariem, Reshma Kassanjee, Inneke Laenen, Sue Le Roux, Richard Lessells, Hassan Mahomed, Deborah Maughan, Graeme Meintjes, Marc Mendelson … & Andrew Boulle
OBJECTIVE: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing of infection to infer the lineage/variant causing infection. METHODS: We included public sector patients aged ≥20 years with laboratory-confirmed COVID-19 between 1-21 May 2022 (BA.4/BA.5 wave) and equivalent prior wave periods. We compared the risk between waves of (i) death and (ii) severe hospitalization/death (all within...

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.

Mary-Ann Davies, Erna Morden, Petro Rosseau, Juanita Arendse, Jamy-Lee Bam, Linda Boloko, Keith Cloete, Cheryl Cohen, Nicole Chetty, Pierre Dane, Alexa Heekes, Nei-Yuan Hsiao, Mehreen Hunter, Hannah Hussey, Theuns Jacobs, Waasila Jassat, Saadiq Kariem, Reshma Kassanjee, Inneke Laenen, Sue Le Roux, Richard Lessells, Hassan Mahomed, Deborah Maughan, Graeme Meintjes, Marc Mendelson … & Andrew Boulle
OBJECTIVE: We aimed to compare clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing of infection to infer the lineage/variant causing infection. METHODS: We included public sector patients aged ≥20 years with laboratory-confirmed COVID-19 between 1-21 May 2022 (BA.4/BA.5 wave) and equivalent prior wave periods. We compared the risk between waves of (i) death and (ii) severe hospitalization/death (all within...

Additional file 1 of Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis

Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar & Nyasha Bakare
Additional file 1: Table S1. Summary of treatment guidelines in South Africa during the Registry period. Table S2. Pre-2021 Treatment outcome definitions used in this study. Table S3. Patient disposition in the South African Registry study. Table S4. Propensity score sensitivity analysis for risk of mortality (EDRWeb data only, end of treatment). Figure S1. Effect of a bedaquiline-based regimen on A treatment success and B mortality (EDRWeb data only, end of treatment) for patient subgroups...

Additional file 2 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 2: Data extraction form. S2.1. Data extraction form.

Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis

Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar & Nyasha Bakare
Abstract Background This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination therapy by evaluating safety, effectiveness, drug utilization and emergence of resistance to bedaquiline. Methods Data were extracted from a register of South African drug-resistant-tuberculosis (DR-TB) patients (Electronic DR-TB Register [EDRWeb]) for newly diagnosed patients with MDR-TB (including pre-extensively drug-resistant [XDR]-TB and XDR-TB and excluding rifampicin-mono-resistant [RR]-TB, as these patients are by definition not multidrug-resistant), receiving either a bedaquiline-containing...

Data from: Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: a retrospective spatiotemporal analysis

Avery I. McIntosh, Helen E. Jenkins, Laura F. White, Marinus Barnard, Dana Thompson, Tania Dolby, John Simpson, Elizabeth M. Streicher, Mary B. Kleinman, Elizabeth J. Ragan, Paul D. Van Helden, Megan B. Murray, Robin M. Warren & Karen R. Jacobson
Background: South Africa has the highest tuberculosis incidence globally (781/100,000), with an estimated 4.3% of cases being rifampicin resistant (RR). Control and elimination strategies will require detailed spatial information to understand where drug-resistant tuberculosis exists and why it persists in those communities. We demonstrate a method to enable drug-resistant tuberculosis monitoring by identifying high-burden communities in the Western Cape Province using routinely collected laboratory data. Methods and findings: We retrospectively identified cases of microbiologically confirmed...

Additional file 3 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 3: Additional figure Figure S3.1. PRISMA diagram

Additional file 3 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 3: Additional figure Figure S3.1. PRISMA diagram

Additional file 1 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 1: Details of the search strategy. S1.1. Database search strategy. S1.1.2. Updated database search strategy. S1.2. Google scholar search strategy. S1.2.2. Updated google scholar search strategy. S1.3. Google engine search strategy.

Data from: Natural selection for the Duffy-null allele in the recently admixed people of Madagascar

Jason A. Hodgson, Joseph K. Pickrell, Laurel N. Pearson, Ellen E. Quillen, Antonio Prista, Jorge Rocha, Himla Soodyall, Mark D. Shriver & George H. Perry
While gene flow between distantly related populations is increasingly recognized as a potentially important source of adaptive genetic variation for humans, fully characterized examples are rare. In addition, the role that natural selection for resistance to vivax malaria may have played in the extreme distribution of the protective Duffy-null allele, which is nearly completely fixed in mainland sub-Saharan Africa and absent elsewhere, is controversial. We address both these issues by investigating the evolution of the...

Data from: High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns

Zizipho Z.A. Mbulawa, Cari Van Schalkwyk, Nai-Chung Hu, Tracy L. Meiring, Shaun Barnabas, Smritee Dabee, Heather Jaspan, Jean-MAri Kriek, Shameem Z. Jaumdally, Etienne Muller, Linda-Gail Bekker, David A. Lewis, Janan Dietrich, Glenda Gray, Jo-Ann S. Passmore, Anna-Lise Williamson & Zizipho Z. A. Mbulawa
Objectives: To investigate prevalence of cervical human papillomavirus (HPV) genotypes to inform HPV vaccination strategy in South Africa and to study factors associated with HPV prevalence. Methods: Sexually active, HIV-negative women, aged 16-22 years recruited from Soweto (n=143) and Cape Town (n=148) were tested for cervical HPV and other genital infections. Results: Overall HPV prevalence was 66.7% (194/291) in young women. Cape Town women were more likely to have multiple HPV infections than the Soweto...

Additional file 4 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 4: Additional tables Table S4.1. Characteristics of identified CMGs. Table S4.2. CMG recommendations for treatment and supportive care. Table S4.3. Oseltamivir treatment and chemoprophylactic doses for children and infants.

Additional file 1 of Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis

Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar & Nyasha Bakare
Additional file 1: Table S1. Summary of treatment guidelines in South Africa during the Registry period. Table S2. Pre-2021 Treatment outcome definitions used in this study. Table S3. Patient disposition in the South African Registry study. Table S4. Propensity score sensitivity analysis for risk of mortality (EDRWeb data only, end of treatment). Figure S1. Effect of a bedaquiline-based regimen on A treatment success and B mortality (EDRWeb data only, end of treatment) for patient subgroups...

Data from: Delays and loss to follow up before treatment of drug-resistant TB following implementation of Xpert MTB/RIF in South Africa: a retrospective cohort study

Helen Cox, Lindy Dickson-Hall, Norbert Ndjeka, Anja Van't Hoog, Alison Grant, Frank Cobelens, Wendy Stevens, Mark Nicol & Anja Van’t Hoog
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for TB diagnosis for all patients with presumptive TB. Routine aggregate data suggest a large treatment gap (pre-treatment loss to follow up) between the numbers of laboratory confirmed RR-TB patients and those reported to have started second-line treatment. We aimed to...

Data from 90-day quantitative inhalation toxicology study evaluating the dose-response and fate in the lung and pleura of chrysotile-containing brake dust

David Bernstein, Balázs Tóth, Rick A. Rogers, Peter Kuzendorf, Dirk Schaudien & James I. Phillips
The final results from this multi-dose, 90-day inhalation toxicology study in the rat with life-time post-exposure observation have shown a significant fundamental difference in pathological response and tumorgenicity between brake dust generated from brake pads manufactured with chrysotile or from chrysotile alone in comparison to the amphiboles, crocidolite and amosite asbestos. The groups exposed to brake dust showed no significant pathological or tumorigenic response in the respiratory track compared to the air control group at...

Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis

Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar & Nyasha Bakare
Abstract Background This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination therapy by evaluating safety, effectiveness, drug utilization and emergence of resistance to bedaquiline. Methods Data were extracted from a register of South African drug-resistant-tuberculosis (DR-TB) patients (Electronic DR-TB Register [EDRWeb]) for newly diagnosed patients with MDR-TB (including pre-extensively drug-resistant [XDR]-TB and XDR-TB and excluding rifampicin-mono-resistant [RR]-TB, as these patients are by definition not multidrug-resistant), receiving either a bedaquiline-containing...

Additional file 2 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 2: Data extraction form. S2.1. Data extraction form.

Additional file 4 of Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Additional file 4: Additional tables Table S4.1. Characteristics of identified CMGs. Table S4.2. CMG recommendations for treatment and supportive care. Table S4.3. Oseltamivir treatment and chemoprophylactic doses for children and infants.

Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti, Reena Joseph, Helen Groves, Peter Hart, Shevin Jacob, Lucille Blumberg, Peter W. Horby & Louise Sigfrid
Abstract Background The COVID-19 pandemic has highlighted the importance of evidence-based clinical decision-making. Clinical management guidelines (CMGs) may help reduce morbidity and mortality by improving the quality of clinical decisions. This systematic review aims to evaluate the availability, inclusivity, and quality of pandemic influenza CMGs, to identify gaps that can be addressed to strengthen pandemic preparedness in this area. Methods Ovid Medline, Ovid Embase, TRIP (Turning Research Into Practice), and Guideline Central were searched systematically...

Registration Year

  • 2023
    2
  • 2022
    15
  • 2018
    1
  • 2017
    2
  • 2014
    1

Resource Types

  • Text
    12
  • Dataset
    5
  • Collection
    4

Affiliations

  • National Health Laboratory Service
    21
  • John Radcliffe Hospital
    10
  • University of Cambridge
    10
  • Wellcome Trust
    10
  • Oxford University Hospitals NHS Trust
    10
  • Liverpool School of Tropical Medicine
    10
  • University of Bristol
    10
  • University of Oxford
    10
  • Stellenbosch University
    6
  • St. Joseph’s Healthcare Hamilton
    4